Rankings
▼
Calendar
CMMB Q1 2018 Earnings — Chemomab Therapeutics Ltd. Revenue & Financial Results | Market Cap Arena
CMMB
Chemomab Therapeutics Ltd.
$12M
Q1 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$12,711
Operating Income
-$3M
Net Income
-$4M
EPS (Diluted)
$-29.54
QoQ Revenue Growth
NaN%
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$12,711
-$11,962
-6.3%
Operating Income
-$3M
-$2M
-66.5%
Net Income
-$4M
-$2M
-54.1%
← FY 2018
All Quarters
Q2 2018 →